Kevin R. Kaster
Direktor/Vorstandsmitglied bei Cure DM, Inc.
Ursprung des Netzwerks ersten Grades von Kevin R. Kaster
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA
17
| Extinct | Biotechnology | 17 |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Cure DM, Inc.
Cure DM, Inc. BiotechnologyHealth Technology Cure DM, Inc. operates as a biopharmaceutical company. It develops new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin. The company was founded by Loraine V. Upham, Claresa S. Levetan and Rita El-Hajj in 2004 and is headquartered in Wilmington, DE.
6
| Subsidiary | Biotechnology | 6 |
Lyric Pharmaceuticals, Inc.
Lyric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lyric Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company. The firm develops novel gastrointestinal therapeutics for unmet medical needs in the hospital settings. The company was founded by David Wurtman and M. Scott Harris in 2013 and is headquartered in South San Fancisco, CA.
4
| Private Company | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kevin R. Kaster
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ALZA CORPORATION | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
SEQUUS Pharmaceuticals, Inc.
SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Alza Development Corp. | Director/Board Member | ||
AKAMAI TECHNOLOGIES, INC. | Data Processing Services | Director/Board Member | |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
AVEDRO, INC. | Medical Specialties | Director/Board Member | |
InfaCare Pharmaceutical Corp.
InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Biotechnology | Director/Board Member Director/Board Member | |
HealthTell, Inc.
HealthTell, Inc. BiotechnologyHealth Technology HealthTell, Inc. develops healthcare diagnosing tools for individuals to monitor their health status. It offers OneTest, a new technology for the early detection and monitoring of progressive diseases and the test is simple and inexpensive, and can be performed with only a single drop of blood. The company was founded in 2010 by Stephen Albert Johnston and Neal Woodbury and is headquartered in Chandler, AZ. | Biotechnology | Director/Board Member | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
Stanford University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal | |
University of Cambridge | College/University | Undergraduate Degree | |
Yale University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Doctorate Degree Undergraduate Degree | |
University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
The University of Colorado | College/University | Undergraduate Degree Undergraduate Degree | |
London School of Economics & Political Science | College/University | Graduate Degree | |
ANAVEX LIFE SCIENCES CORP. | Biotechnology | Director/Board Member | |
Third Point Ventures LLC
Third Point Ventures LLC Investment ManagersFinance Third Point Ventures LLC (Third Point Ventures) is a venture capital subsidiary of Third Point LLC founded in 1995 by Daniel Seth Loeb. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
Xlumena, Inc.
Xlumena, Inc. Medical SpecialtiesHealth Technology Xlumena, Inc. operates as a medical device company. The company was founded by Kenneth F. Binmoeller in 2004 and is headquartered in Mountain View, CA. | Medical Specialties | Director/Board Member | |
Metronome Therapeutics, Inc.
Metronome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metronome Therapeutics, Inc. manufactures and markets oncology drugs. It specializes in developing turnkey finished dosage forms of generic and drugs and has an affiliate assist producers of drugs in the diversification of their product portfolios. The company was founded by George Tidmarsh on January 13, 2006 and is headquartered in Delaware. | Pharmaceuticals: Major | Chief Executive Officer | |
CALITHERA BIOSCIENCES, INC. | Biotechnology | Chairman Director of Finance/CFO | |
JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Channel Medsystems, Inc.
Channel Medsystems, Inc. Electronic Equipment/InstrumentsElectronic Technology Channel Medsystems, Inc. engages in the development of healthcare technologies. The company was founded by Daniel Rogers Burnett and Brian Michael Neil on March 15, 2013 and is headquartered in Emeryville, CA. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
ACELYRIN, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
ODONATE, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Stanford Graduate School of Business | College/University | Masters Business Admin Corporate Officer/Principal | |
Stanford University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
CARISMA THERAPEUTICS, INC. | Biotechnology | Chairman | |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chairman | |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Financial Conglomerates | Director/Board Member | |
MOLECULAR TEMPLATES, INC. | Biotechnology | Director/Board Member | |
Kaerus Bioscience Ltd. | Chairman | ||
Akarna Therapeutics Ltd.
Akarna Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Akarna Therapeutics Ltd. develops novel small molecule therapeutics. It offers non-bile acid FXR agonist, a therapeutic for the treatment of nonalcoholic steatohepatitis and fatty-liver diseases. The company was founded by Raju Mohan in 2014 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Generic | Director/Board Member | |
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Investment Managers | Private Equity Investor |
Statistik
International
Vereinigte Staaten | 44 |
Vereinigtes Königreich | 6 |
Irland | 2 |
Sektoral
Health Technology | 29 |
Consumer Services | 12 |
Finance | 5 |
Health Services | 2 |
Technology Services | 2 |
Operativ
Director/Board Member | 187 |
Corporate Officer/Principal | 70 |
Independent Dir/Board Member | 36 |
Chairman | 30 |
Undergraduate Degree | 28 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Patrick Enright | 41 |
Alan Colowick | 30 |
Chris Christoffersen | 24 |
George Tidmarsh | 22 |
Sanford Zweifach | 22 |
Carter Meyer | 20 |
William Halter | 19 |
Bruce Cozadd | 19 |
Jason Hong | 18 |
Niall O'Donnell | 17 |
George Parker | 15 |
H. Joseph Reiser | 13 |
John M. Amatruda | 12 |
David Hoffmann | 10 |
Peter Davis | 10 |
- Börse
- Insiders
- Kevin R. Kaster
- Unternehmensverbindungen